---
title: Betamethasone + Clotrimazole + Gentamicin + Lidocaine
description: >-
  This combination medication is prescribed for inflammatory skin disorders
  complicated by secondary bacterial and/or fungal infections.  It's
  particularly effective against conditions like tinea pedis, tinea cruris,
  tinea corporis, and acute and chronic eczema.  It is also used in the
  treatment of...
is_banned: false
lastModified: '2025-09-22T17:22:08.206Z'
faqs:
  - q: >-
      What is the recommended dosage for Betamethasone + Clotrimazole +
      Gentamicin + Lidocaine?**


      **A:** Apply a thin layer to affected skin twice daily, typically for a
      duration not exceeding four weeks.  Pediatric and special population
      dosing requires adjustment.
    a: >-
      A:** Apply a thin layer to affected skin twice daily, typically for a
      duration not exceeding four weeks.  Pediatric and special population
      dosing requires adjustment.
  - q: >-
      What conditions does this medication treat?**


      **A:**  Inflammatory skin conditions complicated by bacterial and/or
      fungal infections, such as tinea and eczema, and otitis externa.
    a: >-
      A:**  Inflammatory skin conditions complicated by bacterial and/or fungal
      infections, such as tinea and eczema, and otitis externa.
  - q: |-
      What are the common side effects?**

      **A:**  Local skin irritation, burning, itching, dryness, and redness.
    a: 'A:**  Local skin irritation, burning, itching, dryness, and redness.'
  - q: >-
      Are there any serious side effects?**


      **A:** Rarely, allergic reactions, skin atrophy, or systemic effects with
      excessive or prolonged use.
    a: >-
      A:** Rarely, allergic reactions, skin atrophy, or systemic effects with
      excessive or prolonged use.
  - q: >-
      Can I use this medication during pregnancy or breastfeeding?**


      **A:**  Use with caution and under medical supervision, limiting
      application to small areas and short durations.
    a: >-
      A:**  Use with caution and under medical supervision, limiting application
      to small areas and short durations.
  - q: >-
      How long should I use this medication?**


      **A:**  Typically, no longer than four weeks, unless otherwise directed by
      a physician.  Re-evaluate if no improvement is seen within two weeks.
    a: >-
      A:**  Typically, no longer than four weeks, unless otherwise directed by a
      physician.  Re-evaluate if no improvement is seen within two weeks.
  - q: >-
      Can this cream be used on the face?**


      **A:** Use on the face with caution, avoiding sensitive areas around the
      eyes and mouth, and for limited durations due to the risk of skin
      thinning.
    a: >-
      A:** Use on the face with caution, avoiding sensitive areas around the
      eyes and mouth, and for limited durations due to the risk of skin
      thinning.
  - q: >-
      What should I do if my symptoms worsen or don't improve?**


      **A:** Consult a physician for reassessment and potential alternative
      treatment options.
    a: >-
      A:** Consult a physician for reassessment and potential alternative
      treatment options.
  - q: >-
      Can I apply this medication under a bandage?**


      **A:** Generally avoid occlusive dressings, as they enhance absorption and
      increase the risk of side effects. Only use if specifically directed by a
      physician.
    a: >-
      A:** Generally avoid occlusive dressings, as they enhance absorption and
      increase the risk of side effects. Only use if specifically directed by a
      physician.
---
## **Usage**

This combination medication is prescribed for inflammatory skin disorders complicated by secondary bacterial and/or fungal infections.  It's particularly effective against conditions like tinea pedis, tinea cruris, tinea corporis, and acute and chronic eczema.  It is also used in the treatment of otitis externa.

Its pharmacological classifications include:

* **Corticosteroid:** Betamethasone (anti-inflammatory, antipruritic, vasoconstrictive)
* **Antifungal:** Clotrimazole
* **Antibiotic:** Gentamicin
* **Local Anesthetic:** Lidocaine

**Mechanism of Action:**

* **Betamethasone:** Binds to glucocorticoid receptors, inhibiting inflammatory pathways.
* **Clotrimazole:** Alters fungal cell membrane permeability, leading to cell death.
* **Gentamicin:** Inhibits bacterial protein synthesis by binding to ribosomes.
* **Lidocaine:** Blocks sodium channels, preventing nerve signal transmission and providing local anesthetic action.


## **Alternate Names**

While this combination doesn't have a universally recognized international nonproprietary name (INN), it is often referred to by the combination of its components.  Brand names vary regionally; Triderm is one example.


## **How It Works**

**Pharmacodynamics:** The combined effects produce anti-inflammatory, antipruritic, antifungal, antibacterial, and local anesthetic actions at the site of application.

**Pharmacokinetics:** Topical absorption is limited, though systemic absorption can occur with prolonged or extensive application, especially under occlusion.  Limited information is available on the specific metabolic and elimination pathways of this combination product when applied topically. Individual components, however, are metabolized as follows:

* Betamethasone: Primarily hepatic metabolism, with renal excretion.
* Clotrimazole: Primarily hepatic metabolism.
* Gentamicin: Primarily renal excretion.
* Lidocaine: Primarily hepatic metabolism.

**Mode of Action (Cellular/Molecular):** Betamethasone exerts its effect through intracellular glucocorticoid receptors, affecting gene transcription related to inflammation. Clotrimazole disrupts fungal cell membrane integrity. Gentamicin interferes with bacterial ribosomal function.  Lidocaine binds to voltage-gated sodium channels in neuronal membranes.

**Receptor Binding, Enzyme Inhibition, or Neurotransmitter Modulation:**

* Betamethasone: Glucocorticoid receptor agonist.
* Clotrimazole: Inhibits fungal ergosterol synthesis.
* Gentamicin: No specific receptor binding or enzyme inhibition.
* Lidocaine: Sodium channel blocker.

**Elimination Pathways:**

* Betamethasone: Renal excretion.
* Clotrimazole: Hepatic metabolism.
* Gentamicin: Primarily renal excretion.
* Lidocaine: Primarily hepatic metabolism.



## **Dosage**



### **Standard Dosage**

#### **Adults:**  Apply a thin layer to the affected skin area twice daily (morning and evening). The duration of treatment typically ranges from a few days to a few weeks, depending on the condition and response. Do not use for more than four weeks.

#### **Children:** Use is generally not recommended for children under 17 years of age unless under the specific guidance of a physician.  Pediatric dosages must be carefully determined and monitored due to increased risk of systemic absorption.

#### **Special Cases:**

* **Elderly Patients:**  Close monitoring is advised due to potential age-related changes in skin integrity and drug clearance.
* **Patients with Renal Impairment:** For topical application, dose adjustments are usually not necessary. However, prolonged use or use over large areas should be avoided due to potential for increased systemic absorption.
* **Patients with Hepatic Dysfunction:**  Caution is advised, and the duration and extent of topical application may need to be limited due to the hepatic metabolism of several of the components.
* **Patients with Comorbid Conditions:** Careful consideration should be given to patients with conditions like diabetes, cardiovascular disease, and other conditions that might be affected by any of the components.

### **Clinical Use Cases**

The primary clinical use case for this combination is topical treatment of dermatological infections. Its use in settings like intubation, surgical procedures, mechanical ventilation, ICU use, and emergency situations is not relevant.

### **Dosage Adjustments**

Dosage adjustments may be required in special populations as outlined above. Always consider the patient's specific medical history, age, concomitant medications, and the severity of the infection when determining the appropriate dosage.


## **Side Effects**

### **Common Side Effects:**  Local irritation, burning, itching, dryness, redness, and hypopigmentation.

### **Rare but Serious Side Effects:** Allergic contact dermatitis, skin atrophy, striae, telangiectasia, and systemic effects from absorption (especially in children).  These require prompt medical attention.

### **Long-Term Effects:** Prolonged use of topical corticosteroids can lead to skin thinning, striae, telangiectasia, and other adverse skin reactions.

### **Adverse Drug Reactions (ADR):** Any severe or persistent side effect should be considered an ADR and requires immediate medical attention.


## **Contraindications**

This medication is contraindicated in individuals with hypersensitivity to any of its components.  It should not be used on skin areas affected by tuberculosis, rosacea, perioral dermatitis, and viral skin infections (e.g., herpes simplex, varicella zoster).


## **Drug Interactions**

Clinically significant drug interactions with topical application are unlikely due to limited systemic absorption.  However, concomitant use of oral or parenteral corticosteroids, or other medications metabolized by the liver or kidneys, requires careful monitoring.



## **Pregnancy and Breastfeeding**

Topical use during pregnancy and breastfeeding should be limited to small areas and short durations due to the potential for systemic absorption and fetal/neonatal exposure.  Safety data during pregnancy and breastfeeding are limited. The use of any medication during pregnancy or breastfeeding should be considered only if the potential benefits outweigh the risks to the fetus or infant.


## **Drug Profile Summary**

* **Mechanism of Action:** Combined anti-inflammatory, antifungal, antibacterial, and anesthetic action.
* **Side Effects:** Local irritation, burning, itching; rarely, allergic contact dermatitis or systemic effects.
* **Contraindications:** Hypersensitivity, tuberculous, viral, or rosacea skin lesions.
* **Drug Interactions:** Clinically significant interactions are unlikely with topical use.
* **Pregnancy & Breastfeeding:** Use with caution; limit application area and duration.
* **Dosage:**  Apply thinly twice daily, not exceeding four weeks. Adjust for pediatric or special populations.
* **Monitoring Parameters:**  Observe for local skin reactions and signs of systemic absorption (e.g., Cushingoid features).

## **Popular Combinations**

This is already a combination product. The individual components are sometimes used in other combinations, but those are not relevant to this specific query.

## **Precautions**

Screen for allergies before use.  Avoid prolonged use, occlusion, and application to large skin areas. Caution is advised in patients with pre-existing skin conditions, diabetes, and hepatic or renal impairment.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Betamethasone + Clotrimazole + Gentamicin + Lidocaine?**

**A:** Apply a thin layer to affected skin twice daily, typically for a duration not exceeding four weeks.  Pediatric and special population dosing requires adjustment.

### **Q2: What conditions does this medication treat?**

**A:**  Inflammatory skin conditions complicated by bacterial and/or fungal infections, such as tinea and eczema, and otitis externa.

### **Q3: What are the common side effects?**

**A:**  Local skin irritation, burning, itching, dryness, and redness.

### **Q4: Are there any serious side effects?**

**A:** Rarely, allergic reactions, skin atrophy, or systemic effects with excessive or prolonged use.

### **Q5: Can I use this medication during pregnancy or breastfeeding?**

**A:**  Use with caution and under medical supervision, limiting application to small areas and short durations.

### **Q6:  How long should I use this medication?**

**A:**  Typically, no longer than four weeks, unless otherwise directed by a physician.  Re-evaluate if no improvement is seen within two weeks.

### **Q7: Can this cream be used on the face?**

**A:** Use on the face with caution, avoiding sensitive areas around the eyes and mouth, and for limited durations due to the risk of skin thinning.

### **Q8: What should I do if my symptoms worsen or don't improve?**

**A:** Consult a physician for reassessment and potential alternative treatment options.

### **Q9:  Can I apply this medication under a bandage?**

**A:** Generally avoid occlusive dressings, as they enhance absorption and increase the risk of side effects. Only use if specifically directed by a physician.



